A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity.
about
A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A major responder to ipilimuma ...... with concomitant autoimmunity.
@en
type
label
A major responder to ipilimuma ...... with concomitant autoimmunity.
@en
prefLabel
A major responder to ipilimuma ...... with concomitant autoimmunity.
@en
P2860
P50
P356
P1476
A major responder to ipilimuma ...... with concomitant autoimmunity.
@en
P2093
Gordon Hay
Peter W Szlosarek
P2860
P304
P356
10.1111/PCMR.12607
P577
2017-06-22T00:00:00Z